Advances and future directions of aptamer-functionalized nanoparticles for point-of-care diseases diagnosis
Open Access
- 9 January 2025
- journal article
- Published by Oxford University Press (OUP) in Biology Methods and Protocols
- Vol. 10 (1)
Abstract
Point-of-care (POC) diagnostics have revolutionized disease detection by enabling rapid, on-site testing without the need for centralized laboratory infrastructure. This review presents recent advances in aptamer-functionalized nanoparticles (AFNs) as promising tools for enhancing POC diagnostics, particularly in infectious diseases and cancer. Aptamers, with their high specificity, stability, and modifiability, offer significant advantages over antibodies, while nanoparticles contribute multifunctionality, including signal amplification and targeting capabilities. AFNs have demonstrated up to a 2–10 times increase in detection sensitivity and significant reductions in diagnostic timeframes. We discuss various nanoparticle types, conjugation strategies, real-world applications, and highlight innovative developments such as AI-assisted aptamer design, wearable diagnostic devices, and green nanoparticle synthesis. Challenges related to stability, manufacturing scalability, regulatory hurdles, and clinical translation are critically examined. By merging aptamer precision with nanoparticle versatility, AFNs hold transformative potential to deliver rapid, affordable, and decentralized healthcare solutions, especially in resource-limited settings. Future interdisciplinary research and sustainable practices will be pivotal in translating AFN-based diagnostics from promising prototypes to global healthcare standards.Keywords
This publication has 61 references indexed in Scilit:
- Self-Assembling Nucleic Acid Nanostructures Functionalized with AptamersChemical Reviews, 2021
- Advances in Drug Delivery Nanosystems Using Graphene-Based Materials and Carbon NanotubesMaterials, 2021
- Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapyJournal of Nanobiotechnology, 2021
- Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer TherapyPharmaceutics, 2021
- Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer TherapyInternational Journal of Molecular Sciences, 2020
- Do Aptamers Always Bind? The Need for a Multifaceted Analytical Approach When Demonstrating Binding Affinity between Aptamer and Low Molecular Weight CompoundsJournal of the American Chemical Society, 2020
- Aptamer-T Cell Targeted Therapy for Tumor Treatment Using Sugar Metabolism and Click ChemistryACS Chemical Biology, 2020
- Point of care testing for infectious diseasesClinica Chimica Acta, 2019
- Turn-On Fluoresence Sensor for Hg2+ in Food Based on FRET between Aptamers-Functionalized Upconversion Nanoparticles and Gold NanoparticlesJournal of Agricultural and Food Chemistry, 2018
- Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic reviewHealth Technology Assessment, 2015